Aadi Bioscience, Inc. logo

Aadi Bioscience, Inc.

NASDAQ:AADI

Overview | Financials
Company Name Aadi Bioscience, Inc.
Symbol AADI
Currency USD
Price 1.83
Market Cap 45,045,084
Dividend Yield 0%
52-week-range 1.21 - 6.29
Industry Biotechnology
Sector Healthcare
CEO Mr. David J. Lennon Ph.D.
Website https://aadibio.com

An error occurred while fetching data.

About Aadi Bioscience, Inc.

Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, including tumor

Related Stocks

Talaris Therapeutics, Inc. logo

Talaris Therapeutics, Inc.

TALS

2.72 USD

Eiger BioPharmaceuticals, Inc. logo

Eiger BioPharmaceuticals, Inc.

EIGR

1.725 USD

Radius Health, Inc. logo

Radius Health, Inc.

RDUS

14.68 USD

Akero Therapeutics, Inc. logo

Akero Therapeutics, Inc.

AKRO

26.41 USD

Edgewise Therapeutics, Inc. logo

Edgewise Therapeutics, Inc.

EWTX

17.52 USD

LianBio logo

LianBio

LIAN

0.319 USD

Financials

Numbers are in millions USD

Numbers are in millions USD